Prosthodontic interventions for special-needs patients  by Hosokawa, Ryuji
Editorial
Prosthodontic interventions for special-needs patients
j o u r n a l o f p r o s t h o d o n t i c r e s e a r c h 5 8 ( 2 0 1 4 ) 6 9 – 7 0
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier.com/locate/jporThe Sochi 2014 Paralympic Winter Games recently ended,
leaving great memories. The Paralympic Games is a major
international multi-sport event, involving athletes with a wide
range of physical and intellectual disabilities. According to the
World Health Organization (WHO) World Report on Disability
2011, more than one billion people in the world live with some
form of disability, of whom nearly 200 million experience
considerable functional difficulties. In the years ahead, disabil-
ity will be an even greater concern due to aging populations, the
higher risk of disability in older people, and the global increase
in chronic health conditions such as diabetes, cardiovascular
disease, cancer, and mental health disorders [1]. Disabilities can
affect everyday life; even small acts, such as brushing teeth, can
be problematic in terms of prosthodontic interventions
for patients with special needs. In this regard, I would like to
raise two important systemic intervention-related issues:
xerostomia and immunosuppression.
First, consider xerostomia. Salivary gland hypofunction
can result in xerostomia, or dry mouth, which can greatly
affect the quality of life. The detailed mechanism of this
process is poorly understood, and the therapy is often
complex. In recent years, muscarinic agonists such as
pilocarpine and cevimeline have been used clinically to
activate saliva secretion in patients with Sjo¨gren’s syndrome
and those suffering from side effects of irradiation for head
and neck cancers [2]. However, the therapeutic effect of
muscarinic agonists depends on the individual, and no
definitive treatment for xerostomia has been established.
The prevalence of xerostomia is higher among older and
medicated individuals; therefore, it will likely increase in the
future. Xerostomia results in significant problems in the oral
cavity, such as caries, periodontal and peri-implant diseases,and difficulty wearing dentures; consequently, we must focus
on that symptom with regard to prosthodontic interventions.
Second, immunosuppressive medications. With advances
in medical technology, the transplantation of kidneys, hearts,
and livers is performed in many institutions, with high
success rates. However, the transplant recipient must take
immunosuppressive agents to suppress the rejection of the
transplanted organs. This makes it easier for transplant
recipients to contract infections because the immunosup-
pressive agents also reduce the level of immunity to
infectious disease. In addition, immunosuppressive therapy
is used widely in the treatment of autoimmune diseases.
Nevertheless, there are few reports of the effects of
immunosuppressant administration on dental treatment,
especially prosthodontic interventions. In this issue, Naka-
gawa et al. [3] described the 10-year follow-up of a patient who
received a living-donor lung transplant after dental implant
placement. The authors focused on the status of the implant
in the patient, who was receiving multiple medications,
including immunosuppressants and steroids for the trans-
plant. The article indicated that radiography and periodontal
indices were not affected by the transplant surgery or
subsequent medication. The relationship between implants
and immunosuppressive therapy has been discussed, and the
results are controversial. In fact, most reports were of animal
studies, not clinical investigations. Therefore, well-designed
prospective clinical trials must evaluate the effects of
immunosuppression on patients with prosthodontic inter-
ventions.
Needless to say, in addition to xerostomia or immunosup-
pression, aging is becoming the biggest issue in conjunction
with some form of disability. Japan and other countries face
declining birth rates and aging populations, and Japan is aging
faster than any other country. Consequently, the Japan
Prosthodontic Society has to be more deeply concerned about
prosthodontic interventions for elderly patients. A suggestive
case report (in this issue) by Matsuda et al. [4] stated that ‘‘ease
of maintenance and care’’ is particularly important in the
rapidly increasing elderly population that often requires
extensive nursing care. Naturally, many of the elderly would
be considered special-needs patients, so we must continue
to challenge ourselves regarding special-needs prosthetic
dentistry for the next few decades.
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